Cancer of the Bile Duct
📧 Sign up to get email alerts when something new happens for Cancer of the Bile Duct.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-01-13Clinical Trial Update: Single Agent Regorafenib in Refractory Advanced Biliary Cancers [Phase 2]
Phase 2 clinical trial evaluating single-agent regorafenib in refractory advanced biliary cancers has completed with results posted.
-
CLINICAL_TRIALS withdrawal · 2017-08-01Clinical Trial Update: Study to Test the Benefit and Safety of GM-CT-01 in Combination With 5-FU to Treat Bile Duct and Gall Bladder Cancer [Phase 2]
The Phase 2 trial evaluating GM-CT-01 in combination with 5-FU for bile duct cancer and gallbladder cancer has been withdrawn.